DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Buminate 5% (Albumin) - News

 
 



News related to Buminate 5% (Albumin) and/or conditions it is approved for

Microalbuminuria as a Risk Predictor in Diabetes
Source: Medscape Diabetes & Endocrinology Headlines [2014.04.08]
Do you screen your patients with cardiovascular disease for microalbuminuria? This research suggests that you should.
Diabetes Care

Atrasentan May Work in Diabetic Kidney Disease (CME/CE)
Source: MedPageToday.com - medical news plus CME for physicians [2014.04.11]
(MedPage Today) -- Adding the endothelin receptor antagonist atrasentan to renin-angiotensin blockade reduced albuminuria without major side effects in patients with diabetic nephropathy, researchers found.

Diabetic Nephropathy - Early intervention is the key
Source: The Doctors Lounge - Nephrology
Dr. Riham explains how annual screening for microalbuminuria in diabetic patients will allow early identification of nephropathy.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012